Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam in Bladder Cancer Surgery
NCT04532606Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Feb 2021
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in bladder cancer, sponsored by Peking University First Hospital. Started Feb 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT04532606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04532606.